These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37298573)

  • 21. Imatinib attenuates myocardial fibrosis in association with inhibition of the PDGFRα activity.
    Ma LK; Li Q; He LF; Hua JS; Zhou JL; Yu H; Feng KF; Chen HW; Hu H; Wang L
    Arq Bras Cardiol; 2012 Dec; 99(6):1082-91. PubMed ID: 23184075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PDGF/PDGFR: A Possible Molecular Target in Scleroderma Fibrosis.
    Paolini C; Agarbati S; Benfaremo D; Mozzicafreddo M; Svegliati S; Moroncini G
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409263
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Shirvani P; Fassihi A
    J Biomol Struct Dyn; 2022 Aug; 40(13):5965-5982. PubMed ID: 33475043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular Requirements for the Expression of Antiplatelet Effects by Synthetic Structural Optimized Analogues of the Anticancer Drugs Imatinib and Nilotinib.
    Pantazi D; Ntemou N; Brentas A; Alivertis D; Skobridis K; Tselepis AD
    Drug Des Devel Ther; 2019; 13():4225-4238. PubMed ID: 31849454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Searching for Novel Anaplastic Lymphoma Kinase Inhibitors: Structure-Guided Screening of Natural Compounds for a Tyrosine Kinase Therapeutic Target in Cancers.
    Adnan M; Koli S; Mohammad T; Siddiqui AJ; Patel M; Alshammari N; Bardakci F; Elasbali AM; Hassan MI
    OMICS; 2022 Aug; 26(8):461-470. PubMed ID: 35925819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of novel monoamine oxidase B (MAO-B) inhibitors by combined application of docking-based alignment, 3D-QSAR, ADMET prediction, molecular dynamics simulation, and MM_GBSA binding free energy.
    El Aissouq A; Chedadi O; Bouachrine M; Ouammou A; Khalil F
    J Biomol Struct Dyn; 2023 Jul; 41(10):4667-4680. PubMed ID: 35510607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imatinib mesylate inhibits platelet-derived growth factor receptor phosphorylation of melanoma cells but does not affect tumorigenicity in vivo.
    McGary EC; Onn A; Mills L; Heimberger A; Eton O; Thomas GW; Shtivelband M; Bar-Eli M
    J Invest Dermatol; 2004 Feb; 122(2):400-5. PubMed ID: 15009722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In silico studies on p21-activated kinase 4 inhibitors: comprehensive application of 3D-QSAR analysis, molecular docking, molecular dynamics simulations, and MM-GBSA calculation.
    Gao Y; Wang H; Wang J; Cheng M
    J Biomol Struct Dyn; 2020 Sep; 38(14):4119-4133. PubMed ID: 31556340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of detection of agonist activity by antibodies to platelet-derived growth factor receptor alpha in a subset of normal and systemic sclerosis patient sera.
    Loizos N; Lariccia L; Weiner J; Griffith H; Boin F; Hummers L; Wigley F; Kussie P
    Arthritis Rheum; 2009 Apr; 60(4):1145-51. PubMed ID: 19333919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Three-Dimensional-QSAR and Relative Binding Affinity Estimation of Focal Adhesion Kinase Inhibitors.
    Ghosh S; Cho SJ
    Molecules; 2023 Feb; 28(3):. PubMed ID: 36771129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination of QSAR, molecular docking, molecular dynamic simulation and MM-PBSA: analogues of lopinavir and favipiravir as potential drug candidates against COVID-19.
    Rafi MO; Bhattacharje G; Al-Khafaji K; Taskin-Tok T; Alfasane MA; Das AK; Parvez MAK; Rahman MS
    J Biomol Struct Dyn; 2022 May; 40(8):3711-3730. PubMed ID: 33251975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted mutagenesis on PDGFRα-Fc identifies amino acid modifications that allow efficient inhibition of HCMV infection while abolishing PDGF sequestration.
    Feldmann S; Grimm I; Stöhr D; Antonini C; Lischka P; Sinzger C; Stegmann C
    PLoS Pathog; 2021 Mar; 17(3):e1009471. PubMed ID: 33780515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PDGFRα in liver pathophysiology: emerging roles in development, regeneration, fibrosis, and cancer.
    Kikuchi A; Monga SP
    Gene Expr; 2015; 16(3):109-27. PubMed ID: 25700367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical analysis of platelet-derived growth factor receptor-alpha, -beta, c-kit, c-abl, and arg proteins in glioblastoma: possible implications for patient selection for imatinib mesylate therapy.
    Haberler C; Gelpi E; Marosi C; Rössler K; Birner P; Budka H; Hainfellner JA
    J Neurooncol; 2006 Jan; 76(2):105-9. PubMed ID: 16205964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can structural features of kinase receptors provide clues on selectivity and inhibition? A molecular modeling study.
    Ravichandran S; Luke BT; Collins JR
    J Mol Graph Model; 2015 Apr; 57():36-48. PubMed ID: 25635590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of PDGFRalpha promiscuity and PDGFRbeta specificity in association with PDGFB.
    Torrente D; Cabezas R; Avila M; Sanchez Y; Morales L; Ashraf GM; Barreto GE; Gonzalez J; Aliev G
    Front Biosci (Elite Ed); 2015 Jun; 7(3):434-46. PubMed ID: 25961423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PDGF receptor-α does not promote HCMV entry into epithelial and endothelial cells but increased quantities stimulate entry by an abnormal pathway.
    Vanarsdall AL; Wisner TW; Lei H; Kazlauskas A; Johnson DC
    PLoS Pathog; 2012 Sep; 8(9):e1002905. PubMed ID: 23028311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antitumor activity of S116836, a novel tyrosine kinase inhibitor, against imatinib-resistant FIP1L1-PDGFRα-expressing cells.
    Shen Y; Ren X; Ding K; Zhang Z; Wang D; Pan J
    Oncotarget; 2014 Nov; 5(21):10407-20. PubMed ID: 25431951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B-cell depletion therapy in patients with diffuse systemic sclerosis associates with a significant decrease in PDGFR expression and activation in spindle-like cells in the skin.
    Daoussis D; Tsamandas AC; Liossis SN; Antonopoulos I; Karatza E; Yiannopoulos G; Andonopoulos AP
    Arthritis Res Ther; 2012 Jun; 14(3):R145. PubMed ID: 22697462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of potential platelet-derived growth factor receptor α inhibitors by computational screening and binding simulations.
    Wu H; Gu X; Li J; Wang M; Li Y; Yuan L; Wang J; Ma E
    J Mol Graph Model; 2020 May; 96():107527. PubMed ID: 31918319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.